StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a report released on Friday. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Down 1.9 %

NYSE:ENZ opened at $1.02 on Friday. The business has a 50 day simple moving average of $1.13 and a 200-day simple moving average of $1.12. Enzo Biochem has a 1 year low of $0.99 and a 1 year high of $1.50.

Enzo Biochem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Friday, November 15th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 39.22%. The ex-dividend date is Friday, November 15th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ENZ. XTX Topco Ltd grew its stake in shares of Enzo Biochem by 94.5% during the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after buying an additional 13,735 shares during the last quarter. BBR Partners LLC bought a new stake in shares of Enzo Biochem during the 3rd quarter worth approximately $112,000. Geode Capital Management LLC boosted its holdings in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares during the period. Finally, Renaissance Technologies LLC grew its position in Enzo Biochem by 2.6% in the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after acquiring an additional 64,417 shares during the last quarter. Institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.